$9850 | Site License
$21700 | Global License

Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
[Lowest Price Guaranteed: $9,850]

Published by Venture Planning Group (VPG): 28 Jun 2016 | 59053 | In Stock
Related Topics: Antibodies , Molecular Diagnostics , Office , Pneumonia , Public Health , Respiratory

Introduction

About this Report

This new 366-page report from VPG Market Research presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales forecasts by country and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; thirteen

     -  Reviews features and operating characteristics of major analyzers used 
        for respiratory disease testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies, 
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 366 pages and 108  tables

Table of Contents
for Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review

  • Table of Content - click REQUEST A SAMPLE BUTTON

List Of Tables
in Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review

Competitive Assessments

- Abbott

- Affymetrix

- Beckman Coulter/Danaher

- Becton Dickinson

- bioMerieux

- Bio-Rad

- Cepheid

- Diamedix

- DiaSorin

- Eiken Chemical

- Elitech Group

- Enzo Biochem

- Fujirebio

- Grifols

- Hologic/Gen-Probe

- ID Biomedical/GSK

- Kreatech/Leica

- Lonza

- Ortho-Clinical Diagnostics

- Qiagen

- Roche

- Scienion

- Sequenom

- SeraCare

- Siemens

- Takara Bio

- Thermo Fisher/Life Technology

- Wallac/PE

- Wako

Additional Details

Publisher

Venture Planning Group (VPG)

Publisher Information

Reference

59053 | VPID19144

Number of Pages

366

Report Format

PDF

Venture Planning Group (VPG) Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Respiratory Partnering 2010-2016: Deal trends, players and financials
Global Respiratory Partnering 2010 to 2016 provides the full collection of Respiratory disease deals...
01 Oct 2016 by Current Partnering USD $2,995 More Info
Global Respiratory Syncytial Virus Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Sunovion Respiratory Development Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySunovion Respiratory Development Inc. (Sunovion), a subsidiary of Sunovion Pharmaceuticals In...
12 May 2016 by Global Data USD $250 More Info
Sunovion Respiratory Development Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySunovion Respiratory Development Inc. (Sunovion), a subsidiary of Sunovion Pharmaceuticals In...
16 Mar 2016 by Global Data USD $250 More Info
Respiratory Tract Infections Global Clinical Trials Review, H2, 2015
Respiratory Tract Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical tri...
25 Nov 2015 by Global Data USD $2,500 More Info
Acute Respiratory Failure Global Clinical Trials Review, H2, 2015
Acute Respiratory Failure Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial ...
25 Nov 2015 by Global Data USD $2,500 More Info
Chronic Respiratory Failure Global Clinical Trials Review, H2, 2015
Chronic Respiratory Failure Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical tria...
25 Nov 2015 by Global Data USD $2,500 More Info
Lower Respiratory Tract Infections Global Clinical Trials Review, H2, 2015
Lower Respiratory Tract Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinic...
25 Nov 2015 by Global Data USD $2,500 More Info
Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015
Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's ...
30 Oct 2015 by Global Data USD $2,500 More Info
Physician Views - Breathing new life into patient care; patient-centric services in the respiratory market
Scope According to the Institute of Medicine, patient-centric care can be defined as "providing care...
08 Apr 2014 by FirstWord Pharma USD $695 More Info

This report is published by Venture Planning Group (VPG)

Download Free Report Summary PDF

Respiratory Diseases:  Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...